You have 8 free searches left this month | for more free features.

Advanced melanoma

Showing 9951 - 9975 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced PD-L1 Positive Malignancies Trial in New York (89Zr?DFO?REGN3504)

Terminated
  • Advanced PD-L1 Positive Malignancies
  • New York, New York
  • +1 more
Feb 7, 2022

Marginal Zone Lymphoma Trial in Germany (Obinutuzumab)

Active, not recruiting
  • Marginal Zone Lymphoma
  • Bochum, Germany
  • +15 more
Nov 4, 2022

Malignant Peripheral Nerve Sheath Tumour (MPNST) Trial in Oslo (Pembrolizumab)

Terminated
  • Malignant Peripheral Nerve Sheath Tumour (MPNST)
  • Oslo, Norway
    Oslo university Hospital
Jun 21, 2021

Advanced Head and Neck Squamous Cancer Trial (Panitumumab)

Completed
  • Advanced Head and Neck Squamous Cancer
  • (no location specified)
Oct 19, 2021

Nasopharyngeal Carcinoma Trial in China (SIB-IMRT, Cisplatin)

Unknown status
  • Nasopharyngeal Carcinoma
  • Guangzhou, Guangdong, China
  • +5 more
Jan 28, 2021

Cardiopulmonary Resuscitation Trial in Izmir (cardiopulmonary resuscitation)

Recruiting
  • Cardiopulmonary Resuscitation
  • cardiopulmonary resuscitation
  • İzmir, Turkey
    IKCU, Atatürk Eğitim ve Araştırma Hastanesi, Acil Tıp
Sep 22, 2022

Biliary Tract Cancer Trial in Worldwide (Varlitinib, Capecitabine, Placebo (for Varlitinib))

Completed
  • Biliary Tract Cancer
  • Gilbert, Arizona
  • +20 more
Jul 12, 2021

Central Venous Catheter Placement Trial in Hamburg (Ultrasound-guided wire-in-needle technique for central venous catheter

Recruiting
  • Central Venous Catheter Placement
  • Ultrasound-guided wire-in-needle technique for central venous catheter placement
  • Hamburg, Germany
    University Medical Center Hamburg-Eppendorf
Jul 6, 2022

Differentiated Thyroid Cancer Trial in Philadelphia (Everolimus, Sorafenib)

Active, not recruiting
  • Differentiated Thyroid Cancer
  • Philadelphia, Pennsylvania
    Hospital of the University of Pennsylvania
Oct 18, 2021

Collect Data on Efficacy and Safety of RIBociclib in Older

Recruiting
  • Breast Cancer
  • Leuven, Belgium
    UZ Gasthuisberg Leuven
Mar 17, 2021

Advanced Solid Tumors Cancer Trial in Australia, Israel, United States (ABBV-321)

Completed
  • Advanced Solid Tumors Cancer
  • Springdale, Arkansas
  • +17 more
May 5, 2021

Gastric Cancer, Gastro-esophageal Junction (GEJ) Cancer Trial in Kashiwa (Zolbetuximab)

Completed
  • Gastric Cancer
  • Gastro-esophageal Junction (GEJ) Cancer
  • Kashiwa, Chiba, Japan
    Site JP00001
Mar 3, 2021

Prostate Cancer Trial in United States (Abiraterone acetate, Abiraterone acetate plus degarelix, Degarelix)

Completed
  • Prostate Cancer
  • Abiraterone acetate
  • +2 more
  • Chicago, Illinois
  • +15 more
Oct 25, 2021

NSCLC Trial in Worldwide (PF-06747775, Palbociclib, Avelumab)

Terminated
  • Non-Small Cell Lung Cancer
  • La Jolla, California
  • +14 more
May 13, 2021

Rectal Cancer Trial in Netherlands (FOLFOXIRI Protocol)

Not yet recruiting
  • Rectal Cancer
  • FOLFOXIRI Protocol
  • Eindhoven, Noord-Brabant, Netherlands
  • +6 more
Apr 6, 2021

Lung Squamous Cell Carcinoma, Neoadjuvant Therapy, Immunotherapy Trial in Hangzhou (Tislelizumab)

Recruiting
  • Lung Squamous Cell Carcinoma
  • +2 more
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, Zhejiang University School of med
Aug 22, 2021

Melanoma Trial in China (Ipilimumab, Dacarbazine)

Completed
  • Melanoma
  • Nanjing, Jiangsu, China
  • +7 more
May 5, 2020

NSCLC Trial in Worldwide (Atezolizumab)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Caba, Argentina
  • +111 more
May 25, 2022

Myelodysplastic Syndrome, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Boston (biological, procedure, drug)

Terminated
  • Myelodysplastic Syndrome
  • +2 more
  • GVAX
  • +6 more
  • Boston, Massachusetts
  • +3 more
Jun 30, 2022

Lung Cancer Trial in New Haven, Houston (Erlotinib, AZD6244, MK-2206)

Completed
  • Lung Cancer
  • New Haven, Connecticut
  • +1 more
Dec 14, 2021

Esophageal Cancer Trial in Groningen (Fluorescence endoscopy using durvalumab-680LT)

Not yet recruiting
  • Esophageal Cancer
  • Fluorescence endoscopy using durvalumab-680LT
  • Groningen, Netherlands
    University Medical Center Groningen
Jul 4, 2022

HIV, Sinusitis Trial in United States (Pseudoephedrine HCl, Guaifenesin, Cefuroxime axetil)

Withdrawn
  • HIV Infections
  • Sinusitis
  • Pseudoephedrine hydrochloride
  • +3 more
  • San Diego, California
  • +9 more
Oct 27, 2021

Pancreatic Tumors Trial in Worldwide (BAY86-9766+Gemcitabine)

Completed
  • Pancreatic Neoplasms
  • Aurora, Colorado
  • +22 more
Apr 6, 2021

Smoldering Plasma Cell Myeloma Trial in United States (biological, drug, other)

Recruiting
  • Smoldering Plasma Cell Myeloma
  • Daratumumab
  • +4 more
  • Anchorage, Alaska
  • +595 more
Dec 7, 2022

NSCLC Trial (30 µg OBI-833/100 µg OBI-821, Erlotinib (150 mg daily))

Not yet recruiting
  • Non-small Cell Lung Cancer
  • 30 μg OBI-833/100 μg OBI-821
  • Erlotinib (150 mg daily)
  • (no location specified)
Jun 28, 2022